Related Experiment Video
Updated: Jul 14, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
Understanding and leveraging phenotypic plasticity during metastasis formation
Saumil Shah1, Lisa-Marie Philipp2, Stefano Giaimo3
1Department of Theoretical Biology, Max Planck Institute for Evolutionary Biology, August-Thienemann-Str. 2, 24306, Plön, Germany. shah@evolbio.mpg.de.
NPJ Systems Biology and Applications
|October 6, 2023
Summary
Tumor cells use phenotypic plasticity to adapt during cancer metastasis. This adaptability can protect tumors from treatments, but targeting plasticity may improve cancer therapies.
Area of Science:
- Oncology
- Mathematical Biology
- Systems Biology
Background:
- Cancer metastasis is a major cause of death, driven by tumor cell spread.
- Tumor cells face a trade-off between proliferation and invasion, which they overcome via phenotypic plasticity.
- The role of plasticity in metastasis formation under competitive pressures is not well understood.
Purpose of the Study:
- To investigate how phenotypic plasticity shapes cancer metastasis formation.
- To explore the impact of resource competition between phenotypes on metastasis.
- To analyze the implications of plasticity for cancer treatment strategies.
Main Methods:
- Development of an ecology-inspired mathematical model.
- Inclusion of phenotypic plasticity and resource competition between phenotypes.
- Simulation of tumor cell population dynamics and response to simulated treatments.
Main Results:
- Phenotypically plastic tumor cell populations achieve stable equilibria, maintaining heterogeneity.
- Plasticity can confer resistance to cancer therapies like chemotherapy and immunotherapy.
- The study supports targeting plasticity as an adjuvant therapy strategy.
Conclusions:
- Phenotypic plasticity plays a crucial role in maintaining tumor cell heterogeneity during metastasis.
- Plasticity presents a challenge for cancer treatments but also offers a therapeutic target.
- The model provides a quantitative, testable framework for understanding metastasis and its treatment implications.
Related Concept Videos
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Chemotaxis and Direction of Cell Migration
3.4K
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.4K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

